meglumine has been researched along with Anxiety in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (73.68) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faizullin, RM; Kalugina, AV; Malkin, MP; Miroshnichenko, IY; Pryakhina, KE; Rassokhina, LM; Volchegorskii, IA | 1 |
| Faizullin, RM; Kalugina, AV; Miroshnichenko, IY; Pryakhina, KE; Rassokhina, LM; Volchegorskii, LA | 1 |
| Becker, C; Benoliel, JJ; Blugeot, A; Mauborgne, A; Pohl, M; Rivat, C; Zeau, B | 1 |
| Akiyama, M; Goto, Y; Inagaki, M; Izumi, H; Kaga, M; Li, H; Matsuda, Y; Matsushima, Y; Ohta, H; Seki, M; Toda, T | 1 |
| Guimarães, FS; Netto, CF | 1 |
| Derrien, M; Ducos, B; Durieux, C; McCort-Tranchepain, I; Roques, BP | 1 |
| Belzung, C; Beuzen, A; Misslin, R; Pineau, N | 1 |
| Dooley, DJ; Klamt, I | 1 |
| Adams, JB; Cook, J; Cowley, DS; Pyke, RE; Roy-Byrne, PP; Wingerson, D; Zaccharias, P | 1 |
| Jenck, F; Martin, JR; Moreau, JL | 1 |
| Bradwejn, J; Frankland, PW; Josselyn, SA; Vaccarino, FJ; Yeomans, JS | 1 |
| Adamec, RE; Budgell, J; Shallow, T | 1 |
| Cook, CJ; Jacobson, LH | 1 |
| Little, HJ; Watson, WP; Wilson, J | 1 |
| Acosta, GB | 1 |
| Cohen, H; Kaplan, Z; Kotler, M | 1 |
| Akiyoshi, J; Hikichi, T; Isogawa, K; Kohno, Y; Nagayama, H; Tsutsumi, T | 1 |
| Hughes, J; Hunter, JC; Woodruff, GN | 1 |
| Field, MJ; Hughes, J; Lewis, AS; Singh, L; Woodruff, GN | 1 |
1 review(s) available for meglumine and Anxiety
| Article | Year |
|---|---|
Neurochemical actions of CCK underlying the therapeutic potential of CCK-B antagonists.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Brain; Cholecystokinin; gamma-Aminobutyric Acid; Indoles; Meglumine; Receptors, Cholecystokinin; Spinal Cord; Substance-Related Disorders | 1991 |
1 trial(s) available for meglumine and Anxiety
| Article | Year |
|---|---|
Effect of CI-988, a cholecystokinin-B receptor antagonist, on lactate-induced panic.
Topics: Adult; Anti-Anxiety Agents; Anxiety; Double-Blind Method; Female; Heart Rate; Humans; Indoles; Lactic Acid; Male; Meglumine; Panic Disorder; Psychiatric Status Rating Scales; Receptors, Cholecystokinin | 1996 |
17 other study(ies) available for meglumine and Anxiety
| Article | Year |
|---|---|
Comparative analysis of the anxiolytic effects of 3-hydroxypyridine and succinic acid derivatives.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Female; Male; Meglumine; Picolines; Pyridines; Rats; Risk-Taking; Succinates; Succinic Acid | 2015 |
[Anxiolytic and antidepressant effects of 3-oxypiridine and succinic acid derivatives in alloxan diabetes].
Topics: Animals; Anti-Anxiety Agents; Anxiety; Depression; Diabetes Mellitus, Experimental; Humans; Hyperglycemia; Meglumine; Picolines; Pyridines; Rats; Succinates; Succinic Acid; Thioctic Acid | 2015 |
Chronic stress induces transient spinal neuroinflammation, triggering sensory hypersensitivity and long-lasting anxiety-induced hyperalgesia.
Topics: Analysis of Variance; Animals; Anxiety; Cholecystokinin; Dominance-Subordination; Hyperalgesia; Indoles; Inflammation; Male; Meglumine; Pain Measurement; Pain Threshold; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Reverse Transcriptase Polymerase Chain Reaction; Spinal Cord; Stress, Psychological | 2010 |
Behavioral and cortical EEG evaluations confirm the roles of both CCKA and CCKB receptors in mouse CCK-induced anxiety.
Topics: Adaptation, Physiological; Analysis of Variance; Animals; Anxiety; Behavior, Animal; Brain; Brain Mapping; Brain Waves; Devazepide; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Gene Expression Regulation; Indoles; Injections, Intraventricular; Male; Maze Learning; Meglumine; Mice; Mice, Inbred C57BL; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Spectrum Analysis; Tetragastrin | 2013 |
Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Appetite Depressants; Cell Count; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Hormone Antagonists; Immunohistochemistry; Indoles; Male; Maze Learning; Meglumine; Microinjections; Neurons; Periaqueductal Gray; Proglumide; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Sincalide; Superior Colliculi; Time Factors | 2004 |
Heterogeneity of CCK-B receptors involved in animal models of anxiety.
Topics: Amino Acid Sequence; Animals; Anxiety; Behavior, Animal; Benzodiazepinones; Cholecystokinin; Devazepide; Guinea Pigs; In Vitro Techniques; Indoles; Male; Meglumine; Mice; Molecular Sequence Data; Pancreas; Peptide Fragments; Phenylurea Compounds; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Cholecystokinin | 1994 |
PD135158, a CCK-B antagonist, reduces "state," but not "trait" anxiety in mice.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Cholecystokinin; Darkness; Exploratory Behavior; Indoles; Male; Meglumine; Mice; Mice, Inbred BALB C; Motor Activity | 1994 |
Differential profile of the CCKB receptor antagonist CI-988 and diazepam in the four-plate test.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Diazepam; Dose-Response Relationship, Drug; Electroshock; Exploratory Behavior; Flumazenil; Indoles; Male; Meglumine; Mice; Ondansetron; Receptors, Cholecystokinin | 1993 |
Behavioral effects of CCKB receptor ligands in a validated simulation of panic anxiety in rats.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Benzodiazepinones; Caffeine; Clonazepam; Dose-Response Relationship, Drug; Indoles; Male; Meglumine; Phenylurea Compounds; Rats; Rats, Wistar | 1996 |
Activation of amygdala cholecystokininB receptors potentiates the acoustic startle response in the rat.
Topics: Acoustic Stimulation; Amygdala; Animals; Anti-Anxiety Agents; Anxiety; Benzodiazepinones; Corpus Striatum; Fear; Indoles; Injections, Intraperitoneal; Injections, Intraventricular; Meglumine; Nucleus Accumbens; Pentagastrin; Phenylurea Compounds; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Reflex, Startle | 1997 |
Blockade of CCK(B) but not CCK(A) receptors before and after the stress of predator exposure prevents lasting increases in anxiety-like behavior: implications for anxiety associated with posttraumatic stress disorder.
Topics: Agonistic Behavior; Animals; Anxiety; Arousal; Benzodiazepinones; Cats; Devazepide; Dose-Response Relationship, Drug; Escape Reaction; Fear; Indoles; Male; Maze Learning; Meglumine; Predatory Behavior; Pyrazoles; Rats; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Reflex, Startle; Retention, Psychology; Stress Disorders, Post-Traumatic | 1997 |
Partitioning psychological and physical sources of transport-related stress in young cattle.
Topics: Animals; Anti-Anxiety Agents; Anti-Ulcer Agents; Anxiety; Benzamides; Cattle; Cattle Diseases; Cholecystokinin; Habituation, Psychophysiologic; Heart Rate; Hormone Antagonists; Indoles; Male; Meglumine; Proglumide; Stress, Physiological; Stress, Psychological; Transportation | 1998 |
CCK(B) antagonists protect against anxiety-related behaviour produced by ethanol withdrawal, measured using the elevated plus maze.
Topics: Animals; Anxiety; Dipeptides; Ethanol; Indoles; Male; Maze Learning; Meglumine; Mice; Motor Activity; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Receptors, Serotonin; Substance Withdrawal Syndrome | 1998 |
Administration of cholecystokinin sulphated octapeptide (CCK-8S) induces changes on rat amino acid tissue levels and on a behavioral test for anxiety.
Topics: Alanine; Amino Acids; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Brain; Cerebral Cortex; Corpus Striatum; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Hippocampus; Hypothalamus; Indoles; Lighting; Male; Meglumine; Neurotransmitter Agents; Olfactory Bulb; Rats; Rats, Wistar; Sincalide; Taurine | 1998 |
CCK-antagonists in a rat exposed to acute stress: implication for anxiety associated with post-traumatic stress disorder.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Benzamides; Cholecystokinin; Indoles; Male; Maze Learning; Meglumine; Odorants; Proglumide; Rats; Rats, Wistar; Receptors, Cholecystokinin; Stress Disorders, Post-Traumatic; Stress, Psychological | 1999 |
Suppression of conditioned fear by administration of CCKB receptor antagonist PD135158.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Brain Chemistry; Conditioning, Psychological; Electroshock; Fear; Indoles; Male; Meglumine; Memory; Motor Activity; Panic Disorder; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin | 1999 |
Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.
Topics: Animals; Anxiety; Benzodiazepinones; Cerebral Ventricles; Ceruletide; Chlordiazepoxide; Cholecystokinin; Devazepide; Indoles; Injections, Intraventricular; Male; Meglumine; Pentagastrin; Phenylurea Compounds; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin | 1991 |